Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    August 2017
  1. SARDELLA G, Mancone M, Stio RE, Cavallo E, et al
    Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus.
    Circulation. 2017;136:602-604.
    PubMed     Text format    


    June 2017
  2. HU L, Chang L, Zhang Y, Zhai L, et al
    Platelets Express Activated P2Y12 Receptor in Patients with Diabetes.
    Circulation. 2017 Jun 21. pii: CIRCULATIONAHA.116.026995.
    PubMed     Text format     Abstract available


  3. PAGIDIPATI NJ, Navar AM, Pieper KS, Green JB, et al
    Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes: International Insights from the TECOS Trial.
    Circulation. 2017 Jun 16. pii: CIRCULATIONAHA.117.027252.
    PubMed     Text format     Abstract available


    May 2017
  4. DALE C, Fatemifar G, Palmer T, White J, et al
    Causal Associations of Adiposity and Body Fat Distribution with Coronary Heart Disease, Stroke Subtypes and Type 2 Diabetes: A Mendelian Randomization Analysis.
    Circulation. 2017 May 12. pii: CIRCULATIONAHA.116.026560.
    PubMed     Text format     Abstract available


  5. GOLDBERG RB, Aroda VR, Bluemke DA, Barrett-Connor E, et al
    Effect of Long-term Metformin and Lifestyle in the Diabetes Prevention Program and its Outcome Study on Coronary Artery Calcium.
    Circulation. 2017 May 5. pii: CIRCULATIONAHA.116.025483.
    PubMed     Text format     Abstract available


  6. SAITO Y, Ogawa H, Morimoto T
    Response by Saito et al to Letter Regarding Article, "Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial".
    Circulation. 2017;135:e1010-e1011.
    PubMed     Text format    


  7. AHMED SB, Metcalfe A, Nerenberg K
    Letter by Ahmed et al Regarding Article, "Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial".
    Circulation. 2017;135:e1008-e1009.
    PubMed     Text format    


  8. VAN DE WERF F
    Prevention of Cardiovascular Events in Patients With Diabetes: How Beneficial Is Dual Antiplatelet Therapy?
    Circulation. 2017;135:1675-1676.
    PubMed     Text format    


    April 2017
  9. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Range of Risk Factor Levels: Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.
    Circulation. 2017;135:1522-1531.
    PubMed     Text format     Abstract available


  10. SORENSEN BM, Houben AJ, Martens RJ, Stehouwer CD, et al
    Response by Sorensen et al to Letters Regarding Article, "Prediabetes and Type 2 Diabetes Are Associated With Generalized Microvascular Dysfunction: The Maastricht Study".
    Circulation. 2017;135:e862-e863.
    PubMed     Text format    


  11. BRZEZINSKI RY, Berliner S, Shenhar-Tsarfaty S
    Letter by Brzezinski et al Regarding Article, "Prediabetes and Type 2 Diabetes Are Associated With Generalized Microvascular Dysfunction: The Maastricht Study".
    Circulation. 2017;135:e860-e861.
    PubMed     Text format    


  12. TSUDA K
    Letter by Tsuda Regarding Article, "Prediabetes and Type 2 Diabetes Are Associated With Generalized Microvascular Dysfunction: The Maastricht Study".
    Circulation. 2017;135:e858-e859.
    PubMed     Text format    


    February 2017
  13. YOUNG LH, Viscoli CM, Curtis JP, Inzucchi SE, et al
    Cardiac Outcomes After Ischemic Stroke or TIA: Effects of Pioglitazone in Patients with Insulin Resistance Without Diabetes.
    Circulation. 2017 Feb 28. pii: CIRCULATIONAHA.116.024863.
    PubMed     Text format     Abstract available


  14. CAVENDER MA, White WB, Jarolim P, Bakris GL, et al
    Serial Measurement of High Sensitivity Troponin I and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus in the EXAMINE Trial.
    Circulation. 2017 Feb 28. pii: CIRCULATIONAHA.116.024632.
    PubMed     Text format     Abstract available


  15. BELALCAZAR LM, Ballantyne CM
    Looking Back at Look AHEAD Through the Lens of Recent Diabetes Outcome Trials.
    Circulation. 2017;135:720-723.
    PubMed     Text format    


    January 2017
  16. MAKAM AN, Nguyen OK
    An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.
    Circulation. 2017;135:180-195.
    PubMed     Text format     Abstract available


  17. LINDMAN BR
    The Diabetic HFpEF Phenotype: Is it Real and is it Worth Targeting Therapeutically?
    Circulation. 2017 Jan 4. pii: CIRCULATIONAHA.116.025957.
    PubMed     Text format     Abstract available


  18. KRISTENSEN SL, Mogensen UM, Jhund PS, Petrie MC, et al
    Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients with Heart Failure and Preserved Ejection Fraction. A Report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Tria
    Circulation. 2017 Jan 4. pii: CIRCULATIONAHA.116.024593.
    PubMed     Text format     Abstract available


    November 2016
  19. SAITO Y, Okada S, Ogawa H, Soejima H, et al
    Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes: 10-year Follow-up of a Randomized Controlled Trial.
    Circulation. 2016 Nov 15. pii: CIRCULATIONAHA.116.025760.
    PubMed     Text format     Abstract available


  20. WANG Q, Liu Y, Fu Q, Xu B, et al
    Inhibiting Insulin-Mediated beta2AR Activation Prevents Diabetes-Associated Cardiac Dysfunction.
    Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.022281.
    PubMed     Text format     Abstract available


    October 2016
  21. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    PubMed     Text format    


  22. ALSHEHRY ZH, Mundra PA, Barlow CK, Mellett NA, et al
    Plasma Lipidomic Profiles Improve Upon Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes.
    Circulation. 2016 Oct 18. pii: CIRCULATIONAHA.116.023233.
    PubMed     Text format     Abstract available


  23. CAPODANNO D, Angiolillo DJ
    Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus.
    Circulation. 2016 Oct 11. pii: CIRCULATIONAHA.116.023164.
    PubMed     Text format     Abstract available


    September 2016
  24. SORENSEN BM, Houben AJ, Berendschot TT, Schouten JS, et al
    Prediabetes and Type 2 Diabetes are Associated with Generalized Microvascular Dysfunction: The Maastricht Study.
    Circulation. 2016 Sep 27. pii: CIRCULATIONAHA.116.023446.
    PubMed     Text format     Abstract available


  25. CHENG Z, Garikipati V, Nickoloff E, Wang C, et al
    Restoration of Hydrogen Sulfide Production in Diabetic Mice Improves Reparative Function of Bone Marrow Cells.
    Circulation. 2016 Sep 22. pii: CIRCULATIONAHA.116.022967.
    PubMed     Text format     Abstract available


  26. MANGIACAPRA F, Panaioli E, Colaiori I, Ricottini E, et al
    Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients)
    Circulation. 2016;134:835-7.
    PubMed     Text format    


  27. STOREY RF, Parker WA
    Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus.
    Circulation. 2016;134:793-6.
    PubMed     Text format    


    August 2016
  28. FRANCHI F, Rollini F, Aggarwal N, Hu J, et al
    A Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
    Circulation. 2016 Aug 24. pii: CIRCULATIONAHA.116.023402.
    PubMed     Text format     Abstract available


    July 2016
  29. HEERSPINK HJ, Perkins BA, Fitchett DH, Husain M, et al
    Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes: Cardiovascular and Kidney Effects, Potential Mechanisms and Clinical Applications.
    Circulation. 2016 Jul 28. pii: CIRCULATIONAHA.116.021887.
    PubMed     Text format     Abstract available


  30. YOON CH, Choi YE, Cha YR, Koh SJ, et al
    Diabetes-Induced Jagged 1 Overexpression in Endothelial Cells Causes Retinal Capillary Regression in a Murine Model of Diabetes Mellitus: Insights into Diabetic Retinopathy.
    Circulation. 2016 Jul 12. pii: CIRCULATIONAHA.116.014411.
    PubMed     Text format     Abstract available


  31. KAUL S
    Is the Mortality Benefit With Empagliflozin in Type 2 Diabetes Mellitus Too Good To Be True?
    Circulation. 2016;134:94-6.
    PubMed     Text format    


    June 2016
  32. LOW WANG CC, Hess CN, Hiatt WR, Goldfine AB, et al
    Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.
    Circulation. 2016;133:2459-502.
    PubMed     Text format     Abstract available


    May 2016
  33. CORREA A
    Pre-gestational Diabetes and Congenital Heart Defects.
    Circulation. 2016 May 10. pii: CIRCULATIONAHA.116.022960.
    PubMed     Text format     Abstract available


  34. OYEN N, Diaz LJ, Leirgul E, Boyd HA, et al
    Pre-Pregnancy Diabetes and Offspring Risk of Congenital Heart Disease: A Nation-Wide Cohort Study.
    Circulation. 2016 May 10. pii: CIRCULATIONAHA.115.017465.
    PubMed     Text format     Abstract available


    April 2016
  35. QAMAR A, Bhatt DL
    Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Circulation. 2016;133:1512-5.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: